FXN and neuroblastoma: Actually, another PPAR-γ agonist, azeaolyl PAF, has the ability to increase the expression of frataxin in human neuroblastoma cells, and in primary fibroblasts from FA patients and from healthy controls (Marmolino et al., 2009).